doi:10.3969/j.issn.1673-8640.2016.08.011

Abstract

CLC Number:

R446.1

Figures/Tables 2

References 19

[1]	DOUKETIS J,TOSETTO A,MARCUCCI M,et al.Patient-level meta-analysis:effect of measurement timing,threshold,and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism[J]. Ann Intern Med,2010,153(8):523-531.
[2]	OSHIRO A,YANAGIDA Y,GANDO S,et al.Hemostasis during the early stages of trauma:comparison with disseminated intravascular coagulation[J]. Crit Care,2014,18(2):R61.
[3]	SATHE PM,PATWA UD.D dimer in acute care[J]. Int J Crit Illn Inj Sci,2014,4(3):229-232.
[4]	HOU H,GE Z,YING P,et al.Biomarkers of deep venous thrombosis[J]. J Thromb Thrombolysis,2012,34(3):335-346.
[5]	TANAKA KA,KEY NS,LEVY JH.Blood coagulation:hemostasis and thrombin regulation[J]. Anesth Analg,2009,108(5):1433-1446.
[6]	WADA H,SAKURAGAWA N.Are fibrin-related markers useful for the diagnosis of thrombosis?[J]. Semin Thromb Hemost,2008,34(1):33-38.
[7]	SCHUTGENS RE,HAAS FJ,AGTEROF MJ,et al.The role of fibrin monomers in optimizing the diagnostic work-up of deep vein thrombosis[J]. Thromb Haemost,2007,97(5):807-813.
[8]	PARK KJ,KWON EH,KIM HJ,et al.Evaluation of the diagnostic performance of fibrin monomer in disseminated intravascular coagulation[J]. Korean J Lab Med,2011,31(3):143-147.
[9]	BYKYILMAZ F,SENDIR M,AUTAR R,et al.Risk level analysis for deep vein thrombosis(DVT):a study of Turkish patients undergoing major orthopedic surgery[J]. J Vasc Nurs,2015,33(3):100-105.
[10]	LEE SY,RO DU H,CHUNG C,et al.Incidence of deep vein thrombosis after major lower limb orthopedic surgery:analysis of a nationwide claim registry[J]. Yonsei Med J,2015,56(1):139-145.
[11]	ZENG Y,SHEN B,YANG J,et al.Preoperative comorbidities as potential risk factors for venous thromboembolism after joint arthroplasty:a systematic review and meta-analysis of cohort and case-control studies[J]. J Arthroplasty,2014,29(12):2430-2438.
[12]	OGER E.Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale[J]. Thromb Haemost,2000,83(5):657-660.
[13]	SPENCER FA,EMERY C,LESSAR D,et al.The Worcester Venous Thromboembolism Study:a population-based study of the clinical epidemiology of venous thromboembolism[J]. J Gen Intern Med,2006,21(7):722-727.
[14]	WELLS PS,ANDERSON DR,RODGER M,et al.Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis[J]. N Engl J Med,2003,349(13):1227-1235.
[15]	COSMI B,LEGNANI C,TOSETTO A,et al.Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism:the PROLONG Ⅱ prospective study[J]. Blood,2010,115(3):481-488.
[16]	BECATTINI C,LIGNANI A,MASOTTI L,et al.D-dimer for risk stratification in patients with acute pulmonary embolism[J]. J Thromb Thrombolysis,2011,33(1):48-57.
[17]	OWAIDAH T,ALGHASHAM N,ALGHAMDI S,et al.Evaluation of the usefulness of a D dimer test in combination with clinical pretest probability score in the prediction and exclusion of venous thromboembolism by medical residents[J]. Thromb J,2014,12(1):28.
[18]	YAMAKI T,NOZAKI M,SAKURAI H,et al.Combined use of pretest clinical probability score and latex agglutination D-dimer testing for excluding acute deep vein thrombosis[J]. J Vasc Surg,2009,50(5):1099-1105.
[19]	DOPSAJ V,BOGAVAC-STANOJEVIC N,VASIC D,et al.Excluding deep venous thrombosis in symptomatic outpatients:is fibrin monomer aid to D-dimer analysis?[J]. Blood Coagul Fibrinolysis,2009,20(7):546-551.

组别	例数	术后第1天		术后第3天
组别	例数	DD（mg/L）	FM（mg/L）	DD（mg/L）	FM（mg/L）
并发DVT组	9	3.83±1.82^*	21.37±6.28^*#	11.99±2.64^*	86.1±48.80^*#
未并发DVT组	51	1.08±0.96	10.77±4.75^#	1.66±1.01	13.33±5.63^#

组别	例数	术后第1天		术后第3天
组别	例数	DD（mg/L）	FM（mg/L）	DD（mg/L）	FM（mg/L）
并发DVT组	9	3.83±1.82^*	21.37±6.28^*#	11.99±2.64^*	86.1±48.80^*#
未并发DVT组	51	1.08±0.96	10.77±4.75^#	1.66±1.01	13.33±5.63^#

术后第1天	例数	DD（mg/L）
A	17	0.39±0.08
B	9	0.39±0.09

术后第1天	例数	DD（mg/L）
A	17	0.39±0.08
B	9	0.39±0.09

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 19

Related Articles 15

Recommended Articles

Metrics

[1]	GAO Zikang, CHEN Jing. Construction of a nomogram prediction model for the prognosis of patients with depressive disorder based on the characteristics of peripheral blood lymphocyte subsets [J]. Laboratory Medicine, 2025, 40(12): 1146-1152.
[2]	WANG Tian, ZHANG Yun, BAI Yi, ZHAI Weibin, ZHAO Hai. Roles of PIV，SII and NPAR in the diagnosis of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites [J]. Laboratory Medicine, 2025, 40(12): 1153-1158.
[3]	HUANG Ting, XU Yan, SHI Qingxing, PENG Ying. Roles of miR-944 and MARCH7 mRNA in prognosis assessment of non-small cell lung cancer patients [J]. Laboratory Medicine, 2025, 40(12): 1159-1164.
[4]	LI Minghong, MIN Cuili, GUO Qingbo, MA Lujuan. Predictive roles of serum 25（OH）D and SAA for the response to immunosuppressive therapy in autoimmune hepatitis [J]. Laboratory Medicine, 2025, 40(12): 1165-1170.
[5]	ZHEN Di, JIA Bin, MENG Xianyi. Roles of serum sPD-1 and sTWEAK levels in patients with ulcerative colitis in disease monitoring and prognosis assessment [J]. Laboratory Medicine, 2025, 40(12): 1171-1176.
[6]	ZHAO Yilin, XU Yan, YIN Hui. Roles of serum miR-145-5p，miR-200C-3p and miR-1290 in prognosis assessment of patients with papillary thyroid carcinoma [J]. Laboratory Medicine, 2025, 40(12): 1177-1182.
[7]	LI Song, XIANG Xu. Risk factors for poor prognosis in elderly patients with severe fever and thrombocytopenia syndrome and their clinical significance [J]. Laboratory Medicine, 2025, 40(12): 1183-1189.
[8]	CHANG Nan, WEI Yali, LU Qifeng, LI Tian, HOU Tingting, LI Yuan, ZHU Mengyu, SHEN Yajuan. A machine learning early warning model for acute promyelocytic leukemia based on blood cell analyzer parameters [J]. Laboratory Medicine, 2025, 40(12): 1190-1196.
[9]	. [J]. Laboratory Medicine, 2025, 40(12): 1197-1202.
[10]	. [J]. Laboratory Medicine, 2025, 40(12): 1216-1221.
[11]	. [J]. Laboratory Medicine, 2025, 40(12): 1222-1226.
[12]	BAO Wen. Application and prospect of microsatellite instability determination in tumor diagnosis and treatment [J]. Laboratory Medicine, 2025, 40(12): 1227-1231.
[13]	XIONG Ying, GUO Wei. From generic to personalized：the evolution and frontiers of indirect methods for establishing reference interval [J]. Laboratory Medicine, 2025, 40(11): 1035-1041.
[14]	CHEN Yanqin, FAN Lina, YANG Dagan. Six indirect method algorithms for establishing the reference range of serum cystatin C for adults in Hangzhou and consistency analysis [J]. Laboratory Medicine, 2025, 40(11): 1047-1052.
[15]	LIU Chunyan, NIU Shumin, DENG Zhaohui, LIANG Mengjie, ZHANG Xin. Establishing the reference ranges for AFP，CEA，CA72-4 and CA19-9 in Urumqi region by indirect method [J]. Laboratory Medicine, 2025, 40(11): 1053-1058.